Pectuzumab: Difference between revisions
m Protected "Pectuzumab": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite)) |
m Robot: Automated text replacement (-{{SIB}} +, -{{EH}} +, -{{EJ}} +, -{{Editor Help}} +, -{{Editor Join}} +) |
||
Line 20: | Line 20: | ||
}} | }} | ||
{{SI}} | {{SI}} | ||
==Overview== | ==Overview== | ||
Line 27: | Line 27: | ||
{{humanizedmonoclonals}} | {{humanizedmonoclonals}} | ||
[[Category:Monoclonal antibodies]] | [[Category:Monoclonal antibodies]] | ||
[[Category:Cancer treatments]] | [[Category:Cancer treatments]] | ||
{{WH}} | {{WH}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} |
Latest revision as of 14:51, 20 August 2012
WikiDoc Resources for Pectuzumab |
Articles |
---|
Most recent articles on Pectuzumab |
Media |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Pectuzumab at Clinical Trials.gov Clinical Trials on Pectuzumab at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Pectuzumab
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Pectuzumab Discussion groups on Pectuzumab Patient Handouts on Pectuzumab Directions to Hospitals Treating Pectuzumab Risk calculators and risk factors for Pectuzumab
|
Healthcare Provider Resources |
Causes & Risk Factors for Pectuzumab |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Overview
Pectuzumab is a humanized monoclonal antibody used to treat cancers of epithelial origin. It binds to interleukin-2.
Template:Humanizedmonoclonals
Template:WH
Template:WikiDoc Sources